Results 11 to 20 of about 12,078 (208)
Oxcarbazepine Therapy for Complete Central Diabetes Insipidus [PDF]
Oxcarbazepine and carbamazepine cause hyponatremia by unknown mechanisms. We describe a patient with complete central diabetes insipidus and seizures who developed worsening hyponatremia when her dose of oxcarbazepine was increased.
Basmah Abdallah +4 more
doaj +5 more sources
A review of the chemistry, pharmacology, clinical pharmacology, and clinical use of the antiepileptic drug ...
Nasreddine Wassim M. +2 more
core +5 more sources
Sensitive Electrochemical Determination of Oxcarbazepine using Polymer Film Modified Glassy Carbon Electrode [PDF]
A glassy carbon electrode (GCE) is modified with electropolymerized film of p-aminobenzene sulfonic acid (p-ABSA) in pH 7.0 phosphate buffer solution (PBS).
Esra Rukiye Apaydın +3 more
doaj +4 more sources
Oxcarbazepine-induced Stevens-Johnson Syndrome: A Case Report
Although carbamazepine (CBZ) is the most common cause of Stevens-Johnson syndrome (SJS), a new anticonvulsant, oxcarbazepine, which is structurally related to carbamazepine, has been shown to induce SJS, although extremely rarely.
Lung-Chang Lin +3 more
doaj +2 more sources
The efficacy of oxcarbazepine monotherapy in 60 children and adolescents (aged 6 months to 17.8 years; mean age 8.2 yrs) with partial onset epilepsy was evaluated by retrospective chart review in a study at St Christopher’s Hospital for Children ...
J Gordon Millichap
doaj +2 more sources
Hemophagocytic lymphohistiocytosis associated with oxcarbazepine [PDF]
Hemophagocytic lymphohistiocytosis (HLH) is a rare life-threatening multisystem disorder. Reports of the disorder as a side effect of drugs are extremely rare.
Serkan Kırık +5 more
doaj +2 more sources
Oxcarbazepine-induced Stevens Johnson syndrome: A rare case report
Although carbamazepine is the most common cause of Stevens Johnson syndrome (SJS) a new antiepileptic drug, oxcarbazepine which is structurally related to carbamazepine, has also been rarely shown to induce SJS.
S R Sharma, Nalini Sharma, M E Yeolekar
doaj +2 more sources
Oxcarbazepine in Paroxysmal Dyskinesia
Four unrelated children (ages 8, 9, 16 and 17 years) with idiopathic paroxysmal kinesigenic dyskinesia responding to low dose oxcarbazepine are reported from the Department of Pediatric Neurology, Helen DeVos Children’s Hospital, Grand Rapids, MI.
J Gordon Millichap
doaj +2 more sources
Risk-Benefits of Oxcarbazepine vs Carbamazepine
The clinical differences between oxcarbazepine (OXC) and carbamazepine (CBZ) are reviewed in terms of efficacy, tolerability, and interaction with other drugs in a study at Universitat Bonn, Berlin, Germany.
J Gordon Millichap
doaj +2 more sources
Oxcarbazepine and Hyponatremia
Background and Objectives: Hyponatremia is one of the most common adverse effects in patients treated with oxcarbazepine (OXC). Different risk factors for OXC-induced hyponatremia have been described as age, female gender, dosage, and combination with other drugs During our clinical practice, we noticed that a longer duration of treatment with OXC ...
Julija Čiauškaitė +2 more
openaire +3 more sources

